Chae Hee Kang

1.6k total citations
28 papers, 1.3k citations indexed

About

Chae Hee Kang is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chae Hee Kang has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Immunology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chae Hee Kang's work include Receptor Mechanisms and Signaling (13 papers), Mast cells and histamine (11 papers) and Photosynthetic Processes and Mechanisms (6 papers). Chae Hee Kang is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Mast cells and histamine (11 papers) and Photosynthetic Processes and Mechanisms (6 papers). Chae Hee Kang collaborates with scholars based in United States, United Kingdom and Germany. Chae Hee Kang's co-authors include E. Margoliash, Brian M. Hoffman, Shelagh Ferguson‐Miller, David L. Brautigan, Timothy A. Esbenshade, Arthur A. Hancock, James E. Roberts, James P. Sullivan, Neil Osheroff and Kathleen M. Krueger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Chae Hee Kang

28 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chae Hee Kang United States 19 1.0k 325 317 175 134 28 1.3k
Akwasi Minta United States 10 1.5k 1.5× 903 2.8× 110 0.3× 90 0.5× 124 0.9× 14 2.6k
Jack Peter Green United States 23 998 1.0× 547 1.7× 474 1.5× 43 0.2× 88 0.7× 74 1.9k
Zhe Lü United States 31 2.7k 2.6× 1.4k 4.4× 86 0.3× 86 0.5× 98 0.7× 64 3.5k
Rosa Maria Vitale Italy 28 1.2k 1.2× 184 0.6× 116 0.4× 56 0.3× 113 0.8× 86 2.3k
Christopher A. Ahern United States 34 2.7k 2.7× 1.3k 4.0× 29 0.1× 79 0.5× 123 0.9× 106 3.1k
Jeffrey W. Karpen United States 25 2.2k 2.2× 1.2k 3.7× 79 0.2× 27 0.2× 135 1.0× 50 2.7k
Zhangqiang Li China 16 2.2k 2.2× 888 2.7× 30 0.1× 76 0.4× 62 0.5× 21 2.5k
Dmitry S. Bilan Russia 21 1.1k 1.1× 223 0.7× 92 0.3× 121 0.7× 84 0.6× 47 1.6k
Xiaofeng Zhang China 24 626 0.6× 420 1.3× 83 0.3× 89 0.5× 286 2.1× 58 1.7k
Edward W. Westhead United States 26 1.7k 1.7× 467 1.4× 42 0.1× 60 0.3× 631 4.7× 78 2.5k

Countries citing papers authored by Chae Hee Kang

Since Specialization
Citations

This map shows the geographic impact of Chae Hee Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chae Hee Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chae Hee Kang more than expected).

Fields of papers citing papers by Chae Hee Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chae Hee Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chae Hee Kang. The network helps show where Chae Hee Kang may publish in the future.

Co-authorship network of co-authors of Chae Hee Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Chae Hee Kang. A scholar is included among the top collaborators of Chae Hee Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chae Hee Kang. Chae Hee Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Chae Hee, et al.. (2009). Primary Urothelial Carcinoma of the Upper Urinary Tract in Dialysis Patients with 5-year Follow-up. Japanese Journal of Clinical Oncology. 40(3). 241–246. 18 indexed citations
2.
Yao, B. B., David G. Witte, Ted R. Miller, et al.. (2005). Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor. Neuropharmacology. 50(4). 468–478. 9 indexed citations
3.
Esbenshade, Timothy A., Gerard B. Fox, Kathleen M. Krueger, et al.. (2005). Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties. Journal of Pharmacology and Experimental Therapeutics. 313(1). 165–175. 84 indexed citations
4.
Esbenshade, Timothy A., Gerard B. Fox, Kathleen M. Krueger, et al.. (2004). Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. Biochemical Pharmacology. 68(5). 933–945. 57 indexed citations
5.
Bennani, Youssef L., K. M. Krueger, B. B. Yao, et al.. (2004). Structure-activity relationships of A-331440: a new histamine-3 antagonist with anti-obesity properties. Inflammation Research. 53(0). S79–S80. 2 indexed citations
6.
Witte, David G., Thomas R. Miller, B. B. Yao, et al.. (2003). In vitro pharmacological properties of two novel non-imidazole H 3 receptor (H 3 R) antagonists. Inflammation Research. 52(0). s45–s46. 1 indexed citations
7.
Esbenshade, Timothy A., Kathleen M. Krueger, Thomas R. Miller, et al.. (2003). Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects. Journal of Pharmacology and Experimental Therapeutics. 305(3). 887–896. 85 indexed citations
8.
Esbenshade, Timothy A., Chae Hee Kang, Kathleen M. Krueger, et al.. (2003). Differential Activation of Dual Signaling Responses by Human H1and H2Histamine Receptors. Journal of Receptors and Signal Transduction. 23(1). 17–31. 17 indexed citations
9.
Vasudevan, Anil, Scott E. Conner, Robert G. Gentles, et al.. (2002). Synthesis and evaluation of potent pyrrolidine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 12(21). 3055–3058. 13 indexed citations
10.
Fox, Gerard B., Jia Bao Pan, Timothy A. Esbenshade, et al.. (2002). Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model. Pharmacology Biochemistry and Behavior. 72(3). 741–750. 38 indexed citations
11.
Miller, Thomas R., et al.. (2001). Species-related pharmacological heterogeneity of histamine H3 receptors. European Journal of Pharmacology. 433(2-3). 141–150. 49 indexed citations
13.
Decker, Michael, David J. Anderson, Jorge D. Brioni, et al.. (1995). Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. European Journal of Pharmacology. 280(1). 79–89. 72 indexed citations
14.
Turek, Joseph W., Chae Hee Kang, Jeffrey E. Campbell, Stephen P. Arnerić, & James P. Sullivan. (1995). A sensitive technique for the detection of the α7 neuronal nicotinic acetylcholine receptor antagonist, methyllycaconitine, in rat plasma and brain. Journal of Neuroscience Methods. 61(1-2). 113–118. 81 indexed citations
15.
Kang, Chae Hee & Herbert J. Fromm. (1994). Characterization of the Putative GTP-Binding Site Residues of Escherichia coli Adenylosuccinate Synthetase by Site-Directed Mutagenesis. Archives of Biochemistry and Biophysics. 310(2). 475–480. 14 indexed citations
16.
DeNinno, Michael P., Robert Schoenleber, Robert G. MacKenzie, et al.. (1991). A68930: a potent agonist selective for the dopamine D1 receptor. European Journal of Pharmacology. 199(2). 209–219. 66 indexed citations
17.
Pollock, Nancy J., et al.. (1991). Activation of the 5‐HT1creceptor expressed inXenopusoocytes by the benzazepines SCH 23390 and SKF 38393. British Journal of Pharmacology. 104(4). 1038–1044. 66 indexed citations
18.
Hoffman, Brian M., James E. Roberts, Chae Hee Kang, & E. Margoliash. (1981). Electron paramagnetic and electron nuclear double resonance of the hydrogen peroxide compound of cytochrome c peroxidase.. Journal of Biological Chemistry. 256(13). 6556–6564. 90 indexed citations
19.
Hoffman, Brian M., James E. Roberts, Thomas G. Brown, Chae Hee Kang, & E. Margoliash. (1979). Electron-nuclear double resonance of the hydrogen peroxide compound of cytochrome c peroxidase: identification of the free radical site with a methionyl cluster.. Proceedings of the National Academy of Sciences. 76(12). 6132–6136. 48 indexed citations
20.
Margoliash, E., Shelagh Ferguson‐Miller, Chae Hee Kang, & David L. Brautigan. (1976). Do evolutionary changes in cytochrome c structure reflect functional adaptations?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(10). 2124–30. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026